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Conclusion: HIV patients with OSSN in Botswana are infected with a range of infectious agents which may
represent a unique microbiome. The persistent expressions of gene products by these agents some of which
are oncogenic are likely to contribute to the oncogenic process and suggest that treatment modalities of the
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Abstract 
Purpose: Ocular surface squamous neoplasia (OSSN) is a rare cancer previously seen in elderly men. In 
Botswana there is an increase in OSSN and pterygia among young HIV-1 infected patients. Factors that 
determine the course of this cancer have not been characterized. Recent studies identified HPV, EBV, KSHV, 
HSV-1/2, and CMV in patient samples. We now characterize the microbiome associated with the disease that 
may contribute to its course. Results: Pyrosequencing identified viruses, bacteria, fungus and parasites. Analysis 
of shotgun cloning sequences showed a majority of infectious agents identified by pyrosequencing. Conclusion: 
HIV patients with OSSN in Botswana are infected with a range of infectious agents which may represent a 
unique microbiome. The persistent expressions of gene products by these agents some of which are oncogenic 
are likely to contribute to the oncogenic process and suggest that treatment modalities of the cancer should 
involve the screening for endemic agents. 
Keywords: OSSN, pterygium, HIV-1, microbiome, shotgun cloning, pyrosequencing 
1. Introduction 
Ocular surface squamous neoplasia (OSSN) is a conjunctival or corneal neoplastic growth that encompasses the 
conditions of simple dysplasia to conjunctival intraepithelial neoplasia (CIN) to invasive squamous cell 
carcinoma (Kiire & Dhillon, 2006). Similar to cancer of the cervix, it has a relatively high rate of recurrence 
after treatment and may metastasize (Munoz et al., 2003). OSSN has gained interest in the past few years in its 
association with the HIV-1 pandemic and its increase in incidence is collinear with the increase in HIV-1 
(Mahomed & Chetty, 2002). Prior to the HIV-1 pandemic, OSSN was noted to occur predominantly in the 
elderly for whom it is the third most common oculoorbital tumor after melanoma and lymphoma (Basti & 
Macsai, 2003; Lee & Hirst, 1997). Previously in addition to advanced age and male sex, other risk factors linked 
to its pathogenesis had included ultraviolet light B rays and mutation of the p53 tumor suppressor gene (Kestelyn, 
Stevens, Ndayambaje, Hanssens, & van de Perre, 1990), immunosuppression in organ transplant recipients 
(Spitzer et al., 2008), cigarette smoking, and in some settings, HPV infection (Mahomed & Chetty, 2002; 
McDonnell, McDonnell, Mounts, Wu, & Green, 1986). In Africa, OSSN is becoming more common, more 
aggressive and affects mainly young people, especially females (Kestelyn et al., 1990). 
In addition to OSSN and pterygia, some of the AIDS-related ocular lesions that are associated with viruses 
include cytomegalovirus retinitis, conjunctival Kaposi's sarcoma, herpes zoster ophthalmicus, retinal 
toxoplasmosis, choroidal Pneumocystis carinii infection, herpes simplex and herpes zoster retinitis, and 
cryptococcal choroiditis (Verma & Kearney, 1996). 
Schistosome parasites have been shown to be associated with cancer, and more specifically Schistosoma 
hematobium can cause bladder cancer (Anastos, Hoover, Burk, et al., 2010). Chen and Mott observed that the 
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endemicity of the parasite supports association of bladder cancer with schistosomiasis (Chen & Mott, 1989). 
They also noted that the incidence of bladder cancer in the Middle East and Africa is greater in areas with higher 
Schistoma prevalence and less in areas with lower prevalence (Chen & Mott, 1989). They noted that in tumor 
cases the expression of p53, bcl-2, c-myc, and EGFR was higher in schistosomal bladder tumors (SBT) than in 
non schistosomal bladder tumors (NSBT) while Rb was higher in NSBT than SBT, and that Cyclin D1 was 
expressed in 57.5% of tumors, and was associated with schistosomiasis and early stage well differentiated 
cancers (Anastos et al., 2010). 
Fasciola hepatica (F.hepatica) also known as sheep liver fluke disease, is common in sheep and other domestic 
livestock (Bunnag, Cross, & Bunnag, 2000). Human infection can occur from ingesting watercress in sheep 
raising areas (Bunnag et al., 2000). The life span of adult F. hepatica is between 9 and 13 years. In addition to 
hepatic parenchymal necrosis and abscess formation from migrating larvae, adult flukes cause hyperplasia, 
thickening, desquamation and dilatation of the bile ducts (Bunnag et al., 2000). The oncogenic potential of F. 
hepatica remains unproven at present, with a portion of the available evidence being contradictory. Experimental 
data supports two opposite effects, that is, tumor growth stimulating and tumor growth inhibiting (Sriurairatana, 
Tengchaisri, & Sirisinha, 1996). 
Malaria has also been implicated in cancer. In a recent study Anastos et al. reported higher risk in CIN3+ HIV+ 
women in Rwanda who had recently acquired the malaria parasite (Anastos et al., 2010). Co-infection with 
malaria in HIV-1 patients dysregulates the immune system (Bebell, Pilcher, Dorsey, et al., 2010). Bebell et al. 
observed that acute HIV-1 infections occurred in high HIV prevalence regions of Uganda with low malaria 
endemicity (Bebell et al., 2010). Kelly and Rickinson in their review of Burkitt’s lymphoma pathogenesis 
emphasized the significance of HIV-1 and malaria (Kelly & Rickinson, 2007). 
Though bacteria are the most abundant in the microbiome, not many of them have been associated with cancer. 
However, studies now show a direct association of Helicobacter pylori with gastric adenocarcinoma (Lee & 
Moss, 2007; Peek & Blaser, 2002; Blaser, Perez-Perez, Kleanthous, Cover, et al., 1995; Peek & Blaser, 2002), 
and Bacteroides fragilis with colorectal carcinoma (Sears, 2009; Kim, Lee, & Kim, 2008). Additionally, fungal 
toxins such as aflotoxins from Aspergillus flavus and Aspergillus parasiticus have been associated with liver 
cancer (Kew, 2003). 
These studies suggest the contribution of viruses, bacteria, fungi, and parasitic infections in initiation and 
maintenance of these cancers. The identification of the known oncogenic viruses HPV, KSHV, and EBV in 
OSSN and pterygia tissues suggests that they may contribute to the development of this malignancy in the HIV-1 
infected population (Simbiri, Murakami, Feldman, et al., 2010). The aim of this study was to obtain a more 
comprehensive identification of the associated microbiome in patients with OSSN in the HIV-1 infected 
population in Botswana. The significance of microbes in cancer initiation and maintenance cannot be 
emphasized enough when the many processes they can influence are considered (Table 1). 
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Table 1. Microbial processes associated with cancer initiation 
Mechanism Microbe Cancer Reference 
DNA repair H.pylori Gastric adenocarcinoma PlOS Pathogens (2010) 6 (7) 
S.mansoni Colorectal carcinoma Int J Colorectal Dis (2007) 22:175–181 
O.viverrini Cholangiocarcinoma Parasit Intern.(2012) 61:130-135 
Proliferation H.pylori Gastric adenocarcinoma Expert Opin Ther Targets (2007):11(6)757-769 
S.bovis Colorectal carcinoma Carcinogenesis(2004)25(8):1477-84 
S.haematobium Bladder cancer Mutat Res. (1994) 305:283-292 
O.viverrini Cholangiocarcinoma Int. J. Cancer (1991), 48:821-825 
B.fragilis Colorectal carcinoma Clin Microbiol Rev. 2009 Apr;22(2):349-69 
Apoptosis S.bovis Colorectal carcinoma Carcinogenesis(2004)25(8):1477-84 
B.fragilis Colorectal carcinoma Eur. J. Immunol. 2008. 38: 2190–2199 
Differentiation S.haematobium Bladder cancer Cancer Res. 1994 Apr 1;54(7 Suppl):1929s-1933s 
H.pylori Stomach Nat Rev Cancer 2002;2:28–37 
Carcinogen 
metabolism 
A flavus Liver carcinoma Liver International (2003)23 (6):405-409 
S.haematobium Bladder cancer Cancer Res. 1994 Apr 1;54(7 Suppl):1929s-1933s 
H.pylori Gastric adenocarcinoma Carcinogenesis(2004)25(8):1477-84 
Inflammation H.pylori Gastric adenocarcinoma Cancer Res 1995;55:2111–5 
S.bovis Colorectal carcinoma Carcinogenesis(2004)25(8):1477-84 
B.fragilis Colorectal carcinoma Clin Microbiol Rev. 2009 Apr;22(2):349-69 
C. sinensis Liver carcinoma Parasit Intern.(2012) 61:130-135 
C. sinensis Liver carcinoma Parasit Intern.(2012) 61:130-135 
Immune function H.pylori Gastric adenocarcinoma Nat Rev Cancer 2002;2:28–37 
O.viverrini Cholangiocarcinoma Int.J. Cancer (1991), 48:821-825 
 
S.aureas SCC Skin 
Cancer Epidemiol Biomarkers Prev. (2009) 18(2) 
472-478 
Hormonal 
regulation 
H.pylori Gastric adenocarcinoma Nat Rev Cancer 2002;2:28–37 
S.haematobium Bladder cancer Experimental Parasitology(2009)130:(2)250-253 
B.fragilis Colorectal carcinoma Clin Microbiol Rev. 2009 Apr;22(2):349-69 
The table shows pathogens that have been identified with the development of specific human cancers and the 
mechanistic processes associated with each of the cancers 
 
2. Research Methods 
2.1 Patient Samples 
HIV-1 infected patients with conjunctival lesions seen at Princess Marina Hospital, Gaborone, Botswana from 
April 11 2007 to April 14 2008 were enrolled in this study (IRB #805049 and Ministry of Health, Botswana REF 
NO: PPME 13/18/1 Vol III 141). All patient diagnosis and enrollment were as described previously (Simbiri et 
al., 2010). Briefly, patients were identified by an ophthalmologist in the tertiary care ophthalmology clinic at 
Princess Marina Hospital which serves as the referral center for southern Botswana. All HIV-1 positive patients 
diagnosed using a HIV-ELISA (Abbott Laboratories, Hoofddorp, the Netherlands) with clinical features 
suggestive of OSSN or pterygium were enrolled the day before surgery. Written consent was obtained from each 
subject in either Setswana or English (according to subject’s preference). Tissue specimens obtained in the 
ophthalmology operating room were divided into two pieces by the ophthalmology surgeon - one piece was sent 
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for histopathologic analysis and the other was immediately placed in tissue transport medium for shipment to the 
University of Pennsylvania viral oncology laboratory. Histologic confirmation of each clinical diagnosis was 
obtained from the Botswana National Health Laboratory’s histo-pathologist. 39 patients participated in the study, 
however tissue samples of varying sizes were obtained from only 36 cases. Tissues from patients included in this 
study were 30 whose clinical diagnosis was OSSN and 9 with pterygia (Table 2). The research was approved by 
the University of Pennsylvania ethics committee and adhered to the tenets of the Declaration of Helsinki. Tissue 
specimens were analyzed by histopathology to determine the stage of the cancer and also further analyzed for 
identification of the associated infectious agents. Histological confirmation of clinical diagnosis was determined 
by the University of Pennsylvania resident pathologist.  
 
Table 2. Patient Characteristics 
Case # 
OSSN 
#                    % 
Pterygia 
#               % 
P-value Odds Ratio 
Total 30               (77) 9            (23) 0.79  
Males 11               (37) 2            (22) 0.63 1.6 
Females 19               (63) 7            (77) 0.58 0.81 
Viral load <400 13               (43) 3            (33) 0.56 1.3 
Viral load >400 07               (100) 0            ( 0 ) 0.05 7.0 
Viral load ND 10               (33) 4            (44) 0.47 0.73 
CD4<200 18               (60) 2            (22) 0.29 2.7 
CD4>200 07               (23) 6            (67) 0.91 0.3 
CD4 ND 05               (17) 1            (11) 0.79 1.45 
ART 19               (63) 5            (56) 0.67 1.14 
ART ND 11                (37) 4            (44) 0.69 0.81 
The table shows patient diagnosis, sex, CD4 counts, viral load, and the retroviral therapy (ART) status of each 
patient on enrollment. Patients were diagnosed as OSSN or Pterygia clinically and by histology. There were 
more OSSN with viral load >400 copies/ml, and more pterygia with CD4 counts >200 cells/μl. Because of the 
low number of subjects the P-values based on Fisher’s test did not reach significance level except for viral 
load >400copies/ml in which all were OSSN. However, OR from the table shows that males, subjects with viral 
load <400, subjects with viral load >400, subjects with CD4<200, and subjects under Antiretroviral (ART) are 
more likely to be OSSN than pterygia. 
 
2.2 Pyrosequencing 
Sera samples were prepared using Whole Genome Amplification Procedure based on Qiagen REPLI-g Midi kit 
150043 (Qiagen, Valencia, CA): 200μl of serum were spun down at 6000xg for 10 min and supernatant 
discarded. Pellet was resuspended by adding 50µl TE and vortexing for 5seconds. 10µl denaturation buffer was 
added to the tubes and mixed 3X by pipetting and setting on ice for 10 minutes. 10µl Stop Solution was added to 
each tube containing the lysed cells and mixed by pipetting 3X. Master mix was prepared by mixing 10µl 
nuclease free water, 29µl REPLI-g Midi reaction buffer, 1µl Repli G Midi DNA polymerase (40µl) and added to 
each sample.  
The samples were incubated at 300C overnight at 650C for 3 minutes then stored at -200C until use. 10µl was sent 
for pyrosequencing using 454 (454 Life Sciences, Branford, CT) pyrosequencing technique for global detection 
of foreign sequences expressed in OSSN and pterygia samples. 
2.3 Shotgun Cloning of DNA Extracted from Patient Sera 
We extracted DNA from sera, purified, and then digested with BamH1 restriction enzyme. Briefly, 500μl serum 
was aliquoted into eppendorf tubes and spun at maximum speed of 15,000 rpms at 4°C for 30 minutes. The 
aqueous layer was transferred into new tubes and frozen at -80°C for 1hour to overnight. The pellet was 
resuspended with 250μl of 0.2x PBS. 5μl DNAse and 5μl RNAse was added (from stock of 5mg/ml) and 
incubated at 370C for 1-2 hours. 5μl proteinase-K was added (10mg/ml stock) and incubated for 20 minutes at 
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56°C. The samples were further incubated at 96°C for 10minutes. 5μl Proteinase-K was added and incubated for 
1hour at 56°C. The samples were incubated at 96°C for 30 minutes and volume brought to 500μl with 0.2X PBS. 
Using buffered phenol with Tris pH7.5 1:1, samples were extracted 2X and spun at maximum speed at RT for 5 
minutes. The aqueous layer was transferred into new tubes, and an equal volume of chloroform added and mixed. 
The samples were spun at maximum speed at RT for 5 minutes and transferred to new tubes. 50μl sodium acetate 
(3M) was added and an additional 1ml absolute ethanol was added and incubated o/n at -20°C. The samples were 
spun at 4°C maximum speed for 15minutes and aspirated with drawn out Pasteur pipette. The samples were 
washed 2X with 1ml 70% ethanol by spinning at maximum speed for 5 minutes at RT. The supernatant was 
aspirated, air dried and dissolved in 30μl TE. 10μl of the samples were digested with BamH1 restriction enzyme 
for 3 hours, run on 0.8% Agarose gel. The bands were extracted, purified and ligated into pBluescript vector 
(Agilent Technologies, Santa Clara, CA). Some clones were picked, purified in 0.8% agarose gel and sequenced. 
3. Analysis Result 
3.1 Sequencing of Nucleic Acids from Patient Sera Shows the Presence of Sequences Which Identifies Parasites, 
Bacteria, Viruses, and Fungi Endemic in Sub-Sahara Region 
 
Table 3. Infectious agents identified in sera samples of patients by shotgun cloning 
VIRUSES BACTERIA PARASITES FUNGI 
RNA viruses Gram negative Nematodes 
Schizosaccharomyces 
pombe 
HIV-1 Klebsiella spp Dirofilaria immitis 
Sordariomyceta 
sordariaceae 
Rous sarcoma virus(RSV) Pseudomonas spp* Oncocerca volvulus Agaricales marasmiaceae 
Dengue virus type 3 Salmonella spp* Trichinella spiralis 
Eurotiomycetes 
neosartorya 
Influenza A Neisseria gonorhoea C. elegans 
Tremallaceae 
filobasidiella 
Human respiratory syncytial 
virus 
E. coli spp* Trematodes  
DNA viruses Vibrio spp* Nemertoderma spp*  
Equine herpes virus type 1 Gram positive Sterreria spp*  
HHV-4 Staphylococcus aureas Schmidtea polychroa  
HHV-5 Mycobacterium spp* Fasciola hepatica  
HHV-6 Clostridium spp* Protozoa  
HHV-8 Streptococcus spp* Plasmodium. falciprum  
SV-40  Leishmania. chagasi  
  Trypanosoma spp*  
  
Cryptosporadium 
hominis 
 
  Parasitic vectors  
  Glossina palpalis  
  Culex spp*  
*More than one species detected in samples 
Utilizing shotgun cloning method 500μl serum from patients was aliquoted into eppendorf tubes. The samples 
were spun down at maximum speed for 30 min at 40C. The pellets were resuspended with 250μl 0.2X PBS. 5μl 
DNAse and RNAse (5mg/ml stock) were added to each sample and incubated for 1-2 hours. 5μl of proteinase K 
(10mg/ml stock) was added and incubated for 20min at 56°C. Samples were further incubated at 96°C for 10 
min. 5μl proteinase K was again added and incubated for 1 hr at 56°C followed by denaturation at 96°C for 30 
min. The volume was brought to 500μl with 0.2X PBS. The samples were extracted 2X using buffered phenol 
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with Tris pH 7.5 1:1. Samples were spun down at maximum speed at RT for 5 mins and aqueous layer 
transferred into new tubes into which equal volume of chloroform was added and mixed well. Samples were 
spun down again and transferred into new tubes and 50μl (3M) sodium acetate added. 1ml absolute ethanol was 
added and samples were incubated at -200C overnight. The next day samples were spun down at maximum speed 
at 40C. Ethanol was decanted and 70% ethanol added and samples spun at maximum speed for 5 min at RT. The 
supernatant was aspirated and samples were air dried and dissolved in 30μl TE. We prepared pBluescript vector 
and patient samples by digesting with BamH1. The inserts were ligated into the vector by using T4 ligase and 
incubated overnight at 160C. Products were used to transform DH5α competent cells and plated on ampicillin 
resistant plates overnight. Colonies were selected and DNA was extracted, purified and digested with BamH1 to 
confirm inserts. The samples were then sent for sequencing. RNA viral, DNA viral, bacterial, parasitic and 
fungal sequences were identified in the samples. There were more herpestype viral sequences among the 
identified viruses and more bacterial sequences than all identified pathogenic sequences put together. Fewer 
fungal sequences were observed. 
 
We cloned DNA from sera samples from patients with OSSN and pterygia. The results showed that the samples 
contained sequences from a wide range of bacteria, viruses, parasites, and fungi (Table 3). We also detected 
parasitic vector sequences such as Glossina palpalis and Culex quinquuefasciatus in the samples. The direct 
association and contribution of some of the parasites and the vector moieties to the overall pathology of the 
cancer is not known. Interestingly, we observed a greater number of herpes type viruses that have been 
associated with oncogenesis (McDonnell, 1986; Simbiri et al., 2010; Hoshikawa, Satoh, Murakami, et al. 2002), 
and bacteria, parasites, and fungi whose co-infection leads to enhanced immunosuppression of the HIV infected 
host (Lloyd-Smith, Poss, & Grenfell, 2008; Barnabas, Webb, Weiss, & Wasserheit, 2011). Fungal S. pombe and 
the common free living soil nematode C.elegans were also detected. Thus the implication of identifying both 
parasite and vector, viral, bacterial and fungal sequences in these samples is far reaching in regards to 
immunosuppression, which may result from this onslaught from multiple infectious agents on the 
immunocompromised HIV-1 patients. 
3.2 A Greater Number of Infectious Pathogens are Present in OSSN Patients than in Pterygia Patients Infected 
with HIV-1 
Pyrosequencing of DNA from sera obtained from OSSN and pterygia subjects indicated that patients had been 
exposed to different infectious agents that may contribute to the pathogenesis of OSSN. Additionally, there were 
more sequences of bacteria, followed by viruses, and parasites in patients. A majority of the identified pathogenic 
sequences were higher in the OSSN than pterygium samples (Figure 1, 2, 3). 
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Figure 1. Representative bacterial sequence identified in patient sera 
The figure shows the composition of the bacteria identified showing significant number of the bacteria, their 
species and sub-species in OSSN cases having more sequences and higher reads than pterygia. We also noted 
that OSSN case had extra E.coli subspecies not detected in pterygium, while pterygium had additional 
Acinobacter baumannii subspecies missing in OSSN 
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Figure 2. Representative viral sequences identified in patient sera 
There were more virus reads for OSSN than pterygia. We observed higher reads for Avian carcinoma virus, 
HIV-1, SIV, SV-40, Enterobacteria phage M13, and Y73 sarcoma virus than in pterygium. 
 
 
Figure 3. Representative parasite sequences identified in parasite sera 
There were more parasite reads for OSSN than pterygia. Specifically we noted higher counts of Schmidtea 
polychroa, Schistosoma japonicum, and Schistosoma mansoni. 
 
Samples were prepared using Whole Genome Amplification Procedure based on Qiagen REPLI-g Midi kit 
150043(Qiagen): 200µl of serum were spun down at 6000xg for 10 min and supernatant discarded. Pellet was 
resuspended by adding 50µl TE and vortexing for 5sec. 10µl denaturation buffer was added to the tubes and 
mixed 3X by pipetting and setting on ice for 10 min. 10µl Stop Solution was added to each tube containing the 
lysed cells and mixed by pipetting 3X. Master mix was prepared by mixing 10µl nuclease free water, 29µl 
REPLI-g Midi reaction buffer, 1µl Repli GMidi DNA polymerase (40µl) and added to each sample. The samples 
were incubated at 300C overnight. The polymerase in the samples was inactivated by heating at 65oC for 3 min 
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then storing at -200C until use. 10µl was sent for pyrosequencing using 454 (454 Life Sciences, Branford, CT) 
pyrosequencing technique for global detection of foreign sequences expressed in OSSN and pterygia samples. 
The sequencer uses parallel pyrosequencing technique to generate about a million bases in 7.5hrs run with a read 
of about 250 bases. The uniqueness of this application is that it includes de novo whole genome sequencing 
supported by paired-end mapping, amplicon resequencing, transcriptome analysis that greatly enhanced 
detection of foreign sequences in our samples. Using this technique we were able to detect viruses, bacteria, 
fungi, and parasites.  
Of interest was the detection of more gram-negative bacteria compared to gram positive bacteria, specifically 
those that were present in both OSSN and pterygia, but higher in OSSN than pterygia. Notable were gram 
negative Neisseria gonorrhea a common sexually transmitted bacteria, and the ubiquitous gram positive 
nosocomial agent Staphylococcus aureus. Of significance was the observation of several different subspecies of 
E.coli in OSSN alone and similarly several different subspecies of Acinobacter baumannii in pterygia alone 
(Figure 1). Of the viruses we were surprised at the level of Avian carcinoma virus, Enterobacteria phage M13, 
and Y73 sarcoma virus (Figure 2). The parasitic sequences (Figure 3) were interesting because previous studies 
suggest that some which include S. mansoni and F. hepatica, have been associated with cancer (Chen & Mott, 
1989; Bunnag et al., 2000; Sriurairatana et al., 1996). 
Furthermore, OSSN patient who was more immunosuppressed generated a much higher level of infectious 
agents compared to pterygium patient. Interestingly, there were about a 5-10 fold greater increase in the load of 
bacteria, parasites and viruses seen in OSSN sample compared to pterygia sample (Figure 1, 2, 3). 
4. Discussion 
Our study of OSSN tissues from Botswana HIV-1 infected patients has led to significant findings, namely the 
association of multiple oncogenic viruses with this cancer (Simbiri et al., 2010). In the current study through 
cloning and pyrosequencing, our results showed sequences of additional viruses, bacteria, fungi, and parasites in 
the sera of the patients. There is an increasing amount of investigation examining the modifying effect on host 
susceptibility that one pathogen has on another. Thus many bacterial, viral, and protozoal infections induce 
protective Th1 cell-mediated immune response in resistant individuals while helminth infections lead to 
predominantly Th2 skewing of the immune effector cells (Yang, Gray, Ellis, Yang, Craig, McManus, 2009), yet 
with findings such as ours, little has been done to determine these associations and their effects on the individual 
and the general exposed population. 
To our knowledge this is the first report which demonstrates the co-existence of a significant number of bacteria, 
viruses, parasites, and fungi in OSSN and pterygia patient samples. Pyrosequencing of DNA extracted from sera 
of patient samples confirmed early findings based on cloning and sequencing of similar samples, showing that 
the patients were exposed to many bacteria, viruses, and parasites (by new infections or reactivation of dormant/ 
latent infections) (Lloyd-Smith et al., 2008), infections that could exacerbate the existing immunocompromised 
conditions. From our representative samples, it was noted that OSSN patient with CD4 counts of 134 cells/µl 
and viral load of 120,000 copies /ml was more immunosuppressed having more bacterial, viral and parasitic 
infections than pterygium patient with CD4 counts of 293 cells/µl and viral load of <400 copies /ml. The skewed 
count of E.coli subspecies in OSSN and Acinobacter baumannii subspecies in pterygia may suggest some 
microenvironmental changes due to stage of the disease and specific microbiota load influencing the growth of 
these specific bacteria in the specific subjects. These results build support for multiple infection with other 
agents leading to severe immunosupression from low CD4 cell counts, and chronic stimulation that in addition 
could lead to tolerance and suppression of the expression of cytokines to lower levels than HIV-negative and 
OSSN-negative control drawn from the same region. The depletion of CD4+/CD8+ cells and dysfunction of CD8+ 
cells that play critical roles in defense against most pathogens, including viruses, and can lead to activation of 
herpesviruses which are usually latent (Griffin, Krantz, Selke, Huang, & Wald, 2008; Whitley, Kern, Chatterjee, 
Chou, & Roizman, 1993) may play a significant role during the pathogenesis of the disease in these patients. The 
possibility that oncogenic proteins or immunosuppressive factors from these infectious agents contribute to 
OSSN pathology is thus suggested. Indirectly infectious agents may contribute to cancer by increasing HIV-1 
viral load that leads to more immunosupression thus enhancing oncogenesis and an increase in opportunistic 
infections (Palefsky, 2009). Barnabas et al reported an increase in HIV-1 viral load with malaria, HSV-2, and 
tuberculosis infections (Barnabas, Webb, Weiss, & Wasserheit, 2011). Thus, it is possible that if we have 
immunocompromised patients who are susceptible and infectious then transmissibility of the infectious agents 
can be increased to a level that a strain that would die out in HIV-1 negative individual will be able to 
successfully invade potential hosts and persist. Though our patient cohort was under Antiretroviral Therapy 
(ART) started at different time points, their effects with regards to these infectious agents that also cause 
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immunosupression and some cancers has not been evaluated. It is possible that before ART era AIDS patients 
died before the appearance of HPV and other HIV associated lesions, and that the prolongation of life now 
allows the development of these benign and neoplastic lesions (Meys, Gotch, & Bunker, 2010). There are studies 
that show that the success of ARTs lowering HIV-1 viral load leads to increased opportunistic infections, some of 
which are drug resistant (Palefsky, 2009; Croft, Sundar, & Fairlamb, 2006; Legros, Evans, Maiso, Enyaru, & 
Mbulamberi, 1999). 
Herrera and Ostrosky-Wegman noted that chronic inflammation in host tissues is a common feature of helminth 
infections (Herrera & Ostrosky-Wegman, 2001). The longer the inflammation persists, the higher the risk of 
associated carcinogenesis. Some of our patients showed increased levels of inflammatory cytokines and growth 
factors that support Herrera’s findings (unpublished data). However, in the experiments we observed decreased 
expression of several inflammatory cytokines, a factor possibly resulting from the global immunosupression by 
these infectious agents in an already immunocompromised patient. Some studies have shown that HIV Tat is 
able to penetrate the intact stratified epithelium of the cornea and wounded cornea, allowing rapid and intense 
penetration of Tat into the deeper stratified epithelium and stromal tissue (Guo, Hutcheon, & Zieske, 2004). Thus, 
the secretion of HIV Tat may lead to its penetration of mucosal epithelial cells leading to activation of NF-kB. 
HIV-Tat mediated activation of NF-kB may activate latent herpesviruses because most herpesviral promoters 
have response elements to NF-kB (Santoro, Rossi, & Amici, 2003). Activation of NF-kB may also lead to the 
upregulation of HPV oncoproteins, facilitating the progression of HPV neoplastic processes (Ruutu, Peitsaro, 
Johansson, & Syrjanen, 2002). 
Furthermore, disruption of the corneal epithelium may lead to superinfection with new strains of the viruses thus 
enhancing oncogenesis (Remeijer, Maertzdorf, Buitenwerf, Osterhaus, & Verjans, 2002). The opportunistic 
viruses which we identified in our samples may also activate HIV replication by interacting with the HIV-1 
transcription machinery. Herpesvirus immediate early proteins transactivate HIV-1 long terminal repeat (LTR) 
facilitating HIV replication. HSV-1 immediate early proteins ICP0, ICP4, ICP27, and transactivating proteins 
IE110 and IE175 induce transactivation of HIV-1 LTR by upregulating NF-kB (Margolis, Rabson, Straus, & 
Ostrove, 1992), while EBV EBNA-2 may transactivate HIV-1 LTR in synergy with HIV-1 Tat (Zhang, Guan, 
Park, et al., 1997), and HHV-8 LANA can also activate HIV LTR (Hyun, Subramanian, Cotter, Thomas, & 
Robertson, 2001). Elucidation of the interaction of these factors from the viruses identified in the samples and 
their impact in OSSN pathogenesis will enhance our knowledge of the molecular processes involved that may 
lead to the design of therapeutic molecules to block the activated pathways. 
Raziuddin et al. found that TNF-α levels are greatly elevated in patients with S. haematobium-induced squamous 
cell bladder cancer (Raziuddin, Masihuzzaman, Shetty, & Ibrahim, 1993). Recurrent bacterial urinary tract 
infections are known to be associated with squamous cell carcinomas of the bladder, even in the absence of 
concomitant S. haematobium infection (Badawi, 1996). El-Hawey et al. found that 39–66% of hospitalized 
patients with schistosomiasis had urinary tract bacterial infections (el Hawey, Massoud, Badr el Din, Waheeb, & 
Abd-el Hamid, 1989). Mostafa et al. isolated nitrate-reducing bacteria such as Staphylococcus aureus, 
Staphylococcus albus, Proteus mirabilis, Klebsiella species and Escherichia coli, from urine samples of S. 
haematobium-infected patients (Mostafa, Helmi, Badawi, Tricker, Spiegelhalder, & Preussmann, 1994). Habuchi 
et al. found that 86% of Egyptian patients with schistosome-associated bladder cancer had p53 mutations in 
exons 5, 6, 8 and 10 (Habuchi, Takahashi, Yamada, et al., 1993). Badawi noted that as tumor grade increased, so 
did the p53 mutation rate (Badawi, 1996). Lozano et al. reported that nitric oxide produced by the inflammation 
from schistosomal egg deposition could cause  
p53 mutations through stimulation of endogenous N-nitroso compound generation resulting in DNA alkylation 
(Lozano, Nakazawa, Cros, Cabral, & Yamasaki, 1994). We confirmed S. mansoni sequences in our samples, and 
their contribution to OSSN pathogenesis along with the other infectious agents is intriguing. Studies have shown 
that acute schistosomiasis increased risk of AIDS virus acquisition possibly through Th2 type immunologic 
phenotype and increased viral replication in these cells as shown in Kenyan schistosomiasis patients with HIV-1 
coinfection producing decreased levels of IL-4 and IL-10 compared to patients with schistosomiasis alone 
(Mwinzi, Karanja, Colley, Orago, & Secor, 2001). However, we are not able to predict that the viral and bacterial 
interactions observed in S. mansoni infections and p53 mutations contributed to OSSN pathogenesis in our 
cohort. 
Malaria whose sequences were also confirmed has been associated with HIV-1 infection and incidence of 
symptomatic episodes which may be severe or uncomplicated and the corresponding parasite density has been 
reported to be higher in HIV-1 infected individuals with low CD4 counts (Korenromp, Williams, de Vlas, et al., 
2005). Some studies have shown increased viral load with acute malaria and decreased viral load following 
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treatment (Barnabas et al., 2011). 
Mycobacterium tuberculosis one of the many bacteria whose sequences we identified has been defined as a 
syndemic (convergence of two or more diseases that act synergistically to magnify the burden of disease) with 
HIV-1 (Kwan & Ernst, 2011). HIV-1 causes the depletion of CD4 T cells contributing to susceptibility of 
coinfected individuals to TB, as this T cell subset is significant in the control of TB and a majority of HIV-1 
infected individuals are now coinfected with TB (Diedrich & Flynn, 2011). 
5. Conclusion 
Our studies identified sequences from many bacteria, viruses, parasites and fungi in OSSN and pterygia from the 
HIV-1 infected population suggesting that multiple pathogenic agents may have a role in development of this 
disease. The interaction between different pathogenic agents and the dysregulatory activities of oncogenic 
moieties and other antigenic factors in immunocompromised individuals may contribute to oncogenic 
transformation. The processes, pathways, and levels of interaction of the different pathogen oncogenic moieties 
in initiating oncogenesis require further studies. Clearly, there is a need to elucidate the molecular processes and 
pathways involved in pathogenesis of OSSN and pterygia in the HIV population that may lead to development of 
therapies to control and prevent the diseases. In the Botswana population, it is possible that co infections, the 
minimal use of parasitic drugs, the innate ability of rapidly evolving organisms to attain resistance to commonly 
used therapy and the suppression of cell mediated immunity that occurs with AIDS has led to an increase in 
many common infectious diseases that often act in synergy and may have contributed to the initiation and 
increased pathogenesis of OSSN. 
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